Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Mark J. Buchfuhrer"'
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background There is a large population of restless legs syndrome (RLS) patients who are refractory to medication. Whereas experts recommend off-label opioids as an effective long-term treatment for refractory RLS, reducing opioid dose could
Externí odkaz:
https://doaj.org/article/3fc405dd4b9e435785ecaf3c8bd0b004
Autor:
Mark J. Buchfuhrer, MD, Wayne A. Hening, "MD, PhD", Clete A. Kushida, MD
The Restless Legs Syndrome Foundation estimates that up to 8 percent of the population suffers with restless legs syndrome (RLS). The hallmark of this neurologic disorder is an irresistible urge to move, most commonly at night. It causes uncomfortabl
Publikováno v:
Journal of Clinical Sleep Medicine.
Autor:
Silber, Michael H.
Publikováno v:
In Sleep Medicine 2008 9(7):809-809
Autor:
Harnadar Anand, Haramandeep Singh, Viktoriia Kolotovska, Jonathan D Charlesworth, Mehvish Ismail, Shriram Raghunathan, Fiona C. Baker, Mark J. Buchfuhrer, Bahman Adlou, Massimiliano de Zambotti
Publikováno v:
J Clin Sleep Med
STUDY OBJECTIVES: Restless legs syndrome (RLS) is a common neurological disorder characterized by an uncontrollable nocturnal urge to move the legs and often associated with chronic sleep disturbances. The most common treatments for RLS are medicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a30a6c6023f196c33640db230a2e9c5
https://europepmc.org/articles/PMC8656897/
https://europepmc.org/articles/PMC8656897/
Autor:
Birgit Högl, Irena Laska, Rochelle S. Zak, Lynn Marie Trotti, Hailey Meaklim, Arthur S. Walters, Luigi Ferini Strambi, Marco Zucconi, Laurel A. Schaefer, Evi Holzknecht, Philip M. Becker, Denise Sharon, Richard K. Bogan, Ambra Stefani, Richard P. Allen, John Swieca, Sara Marelli, Mark J. Buchfuhrer, Victoria Olvera, Pablo Martinez-Martin, Jennifer G. Hensley
Publikováno v:
Sleep Medicine. 54:94-100
Introduction The International Restless Legs Study Group (IRLSSG) has developed the IRLS (International Restless Legs Syndrome Severity Scale) and validated it as a clinician/researcher administered scale to be used when both patient and examiner are
Autor:
Michael H. Silber, Mark J. Buchfuhrer, Christopher J. Earley, Brian B. Koo, Mauro Manconi, John W. Winkelman, Phillip Becker, J. Andrew Berkowski, Stefan Clemens, James R. Connor, Sergi Ferré, Jennifer G. Hensley, Byron C. Jones, Elias G. Karroum, Brian Koo, William Ondo, Kathy Richards, Denise Sharon, Lynn Marie Trotti, George Uhl, Arthur S. Walters
Publikováno v:
Mayo Clinic proceedings. 96(7)
Restless legs syndrome (RLS) is a common disorder. The population prevalence is 1.5% to 2.7% in a subgroup of patients having more severe RLS with symptoms occurring 2 or more times a week and causing at least moderate distress. It is important for p
Autor:
Philip M. Becker, John W. Winkelman, Arthur S. Walters, William G. Ondo, Mark J. Buchfuhrer, Scientific, Michael H. Silber, Christopher J. Earley
Publikováno v:
Mayo Clinic Proceedings. 93:59-67
Restless legs syndrome (RLS) is a distinct disorder, differing from chronic pain in many ways. Refractory RLS is characterized by unresponsiveness to dopamine agonists or alpha-2-delta ligands due to inadequate efficacy, augmentation, or adverse effe
Autor:
William G. Ondo, Ryan Hays, Mansoor Ahmed, Alon Y. Avidan, Mark J. Jaros, Daniel O. Lee, Gwendoline Shang, Mark J. Buchfuhrer, Richard Kim, Diego Garcia-Borreguero
Publikováno v:
Sleep Medicine. 19:50-56
Aim Assess efficacy and tolerability of gabapentin enacarbil (GEn) in adults with severe primary restless legs syndrome (RLS). Methods We pooled data from three 12-week, double-blind, placebo-controlled, randomized trials (NCT00298623, NCT00365352, N
Autor:
Fiona C. Baker, B Adlou, Mark J. Buchfuhrer, S Raghunathan, J D Charlesworth, H Singh, Kolotovska, M Ismail, M de Zambotti
Publikováno v:
Sleep. 43:A302-A302
Introduction Restless Legs Syndrome (RLS) is a sensorimotor neurological condition characterized by an uncontrollable urge to move the legs that interferes with falling and staying asleep. For the over 5 million Americans with clinically significant